Skip to content

Mereo BioPharma Plc

MREO

Latest QuantConomy context for MREO: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
5
Asset profile

Mereo BioPharma Plc

QuantConomy has a structured record for MREO. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
MREO
Name
Mereo BioPharma Plc
Coverage
3 market/data records
Sources
alpaca fmp alphavantage sec nasdaq lse
Latest signal rows

Recent signals for MREO

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
earnings release
neutral
40
May 12, 12:00 AM MREO filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
other event
neutral
40
May 14, 02:25 PM MREO filed 8-K: Shareholder Vote Results - [weak neutral signal]
earnings
neutral
75
May 12, 01:00 PM MREO filed 8-K: Earnings Release - 1 material event - [strong neutral signal]

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market coverage

Market Exchange Source Asset record
MREO NASDAQ alpaca Mereo BioPharma Group plc American Depositary Shares
MREO NASDAQ fmp Mereo BioPharma Group plc
MREO NASDAQ alphavantage Mereo Biopharma Group Plc

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
5
Date Insider Role Type Shares Price Value Filing
Feb 1, 2026 Fox Christine Ann Chief Financial Officer grant 315,750 4 on EDGAR
Feb 1, 2026 Hughes-Wilson Alexandra See Remarks grant 183,750 4 on EDGAR
Feb 1, 2026 Lewicki John A. Chief Scientific Officer grant 139,913 4 on EDGAR
Feb 1, 2026 Scots-Knight Denise Chief Executive Officer grant 1,035,000 4 on EDGAR
Feb 1, 2026 Sermon Charles General Counsel grant 315,750 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query MREO context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access